Martin C Tammemägi, Gail E Darling, Heidi Schmidt, Meghan J Walker, Deanna Langer, Yvonne W Leung, Kathy Nguyen, Beth Miller, Diego Llovet, William K Evans, Daniel N Buchanan, Gabriela Espino-Hernandez, Usman Aslam, Amanda Sheppard, Aisha Lofters, Micheal McInnis, Julian Dobranowski, Steven Habbous, Christian Finley, Marianne Luettschwager, Erin Cameron, Caroline Bravo, Anna Banaszewska, Katherin Creighton-Taylor, Brenda Fernandes, Julia Gao, Alex Lee, Van Lee, Bogdan Pylypenko, Monica Yu, Erin Svara, Shivali Kaushal, Lynda MacNiven, Caitlin McGarry, Lauren Della Mora, Liz Koen, Jessica Moffatt, Michelle Rey, Marta Yurcan, Laurie Bourne, Gillian Bromfield, Melissa Coulson, Rebecca Truscott, Linda Rabeneck
Globally, lung cancer is the leading cause of cancer death. Previous trials demonstrated that low-dose computed tomography lung cancer screening of high-risk individuals can reduce lung cancer mortality by 20% or more. Lung cancer screening has been approved by major guidelines in the United States, and over 4,000 sites offer screening. Adoption of lung screening outside the United States has, until recently, been slow. Between June 2017 and May 2019, the Ontario Lung Cancer Screening Pilot successfully recruited 7,768 individuals at high risk identified by using the PLCOm2012noRace lung cancer risk prediction model...
April 2024: Nature Medicine